Unsurprisingly, many of above pathways’ transcripts encode known oncoproteins and tumor suppressors such as Myc, PTEN, p53 and IDH1/2 whose mutation, expression level and/or de-regulation frequently correlate with various individual cancers and their outcomes (SI Appendix Table S1) [11, 35–41]. This evidence concerns the gene TP53 and cancer.